MicroRNAs each regulate multiple messenger RNAs in the body. InteRNA Technologies aims to develop improved treatments for cancer by harnessing microRNAs, or miRNAs, as therapeutics with more than one mode of action. CEO Roel Schaapveld discussed the company’s work, the challenges it still faces, and its preparations to enter clinical development.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?